1. Idiopathic Pulmonary Fibrosis: Adaptive Multiple Features Method Fibrosis Association with Outcomes. Salisbury ML, Lynch DA, van Beek EJ, Kazerooni EA, Guo J, Xia M, Murray S, Anstrom KJ, Yow E, Martinez FJ, Hoffman EA, Flaherty KR; IPFnet Investigators. Am J Respir Crit Care Med. 2016 Oct 21.
2. Imaging biomarkers in the clinic. van Beek EJ. Biomark Med. 2016 Oct;10(10):1073-1079
3. Nicol L, Mills R, Seth S, MacKinnon A, McFarlane P, William W, Stewart G, Howie S, Dhaliwal D, Murchison J, Hirani N. Prognostically predictive biomarkers for IPF; a longitudinal cohort study of treatment naive patients. ABSTRACT; Quarterly J Med 2016
http://qjmed.oxfordjournals.org/content/109/suppl_1/S38.1 4. O'Dwyer DN, Armstrong ME, Trujillo G, Cooke G, Keane MP, Fallon PG, Simpson AJ, Millar AB, McGrath EE, Whyte MK, Hirani N, Hogaboam CM, Donnelly SC..The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med.2013 Dec 15;188 (12):1442-50